Physician profile
Mariah Williams
NPI 1982173167
$3,809.05
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,450 · 2022: $1,280 · 2023: $32.43 · 2024: $46.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $830.69 | 2021-2024 | |
| Novo Nordisk INC | $733.72 | 2021-2022 | |
| Esperion Therapeutics, INC. | $539.30 | 2021-2022 | |
| Lilly USA, LLC | $314.44 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $214.05 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $208.08 | 2021-2022 | |
| Eisai INC. | $200.05 | 2021-2022 | |
| Amarin Pharma, INC. | $171.85 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $96.73 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $84.54 | 2022 | |
| Novartis Pharmaceuticals Corporation | $75.00 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.23 | 2021 | |
| Jazz Pharmaceuticals INC. | $61.25 | 2021 | |
| Glaxosmithkline, LLC. | $47.01 | 2021-2022 | |
| Daiichi Sankyo INC. | $45.00 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $32.62 | 2021 | |
| Sanofi-Aventis U.S. LLC | $26.72 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.25 | 2021 | |
| Merck Sharp & Dohme LLC | $16.26 | 2021 | |
| Currax Pharmaceuticals LLC | $14.04 | 2021 | |
| Dexcom, INC. | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariah Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.